- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 27.07. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | 1 | ASX | ||
| 22.07. | VITURA HEALTH LIMITED: Vitura announces new senior appointments | - | ASX | ||
| 09.07. | VITURA HEALTH LIMITED: Change of Address | - | ASX | ||
| 05.06. | VITURA HEALTH LIMITED: Appointment of Interim Chief Financial Officer | - | ASX | ||
| 05.06. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 03.06. | VITURA HEALTH LIMITED: Chief Financial Officer Resignation | - | ASX | ||
| 27.05. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 27.05. | VITURA HEALTH LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 20.05. | VITURA HEALTH LIMITED: Former CEO Legal Action Initiated | - | ASX | ||
| 28.04. | VITURA HEALTH LIMITED: Business Transformation Update | - | ASX | ||
| 21.04. | Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million | 1 | smallcaps.com.au | ||
| 21.04. | VITURA HEALTH LIMITED: Doctors on Demand Performance Update | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Resignation of Non-Executive Director | - | ASX | ||
| 02.04. | VITURA HEALTH LIMITED: Appointment of Chief Executive Officer | - | ASX | ||
| 29.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 22.03. | VITURA HEALTH LIMITED: Cortexa advances commercialisation of MDMA supply | - | ASX | ||
| 17.03. | Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products | 2 | smallcaps.com.au | ||
| 17.03. | VITURA HEALTH LIMITED: VIT enters distribution agreement with MedReleaf Australia | - | ASX | ||
| 12.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,422 | +0,25 % | Aurora Cannabis Inc (3): Aurora gets ISS backing ahead of annual meeting vote | ||
| TILRAY BRANDS | 3,915 | -0,89 % | Tilray Brands dreht auf - dieses Signal zählt jetzt | ||
| ORGANIGRAM GLOBAL | 0,843 | +3,56 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| SNDL | 1,052 | -0,94 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,665 | -2,92 % | Noveris Health Sciences Inc.: Noveris Health Sciences Joins BioAlberta | Vancouver, British Columbia--(Newsfile Corp. - July 30, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces that it has become a... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen | |
| BIONANO GENOMICS | 1,065 | 0,00 % | Bionano Genomics: Bionano Announces Hiring of Chief Scientific Officer | SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 8,912 | +2,55 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026 | ||
| HIGH TIDE | 1,876 | +2,07 % | High Tide schließt Übernahme von Northern Helm ab - vier Cannabis-Einzelhandelsgeschäfte in Ontario kommen hinzu | CALGARY, AB, 30. Juli 2026 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), das erfolgreiche, auf den Einzelhandel ausgerichtete Unternehmen... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 5,489 | 0,00 % | Achieve Life Sciences Announced Granting of New Hire Inducement Awards | ||
| JAGUAR HEALTH | 1,010 | +1,00 % | Jaguar Health, Inc.: Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog | Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,005 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| MEDIPHARM LABS | 0,046 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer's Disease and Dementia | Results presented by the LiBBY study team at the Alzheimer's Association International Conference ("AAIC") demonstrated statistically significant improvements in agitation symptoms compared with placebo.The... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,017 | +10,00 % | ARGENT BIOPHARMA LIMITED: CannEpil Global Licence Expands into Veterinary Healthcare | ||
| AYR WELLNESS | 0,050 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
Das Unternehmen VITURA HEALTH LIMITED kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,010 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.